Tumor necrosis factor receptor superfamily member 11A

Hughes AE et. al. (1994) Genetic linkage of familial expansile osteolysis to chromosome 18q.

Whyte MP et. al. (2014) Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.

Tan W et al. (2011) Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.

Gonzalez-Suarez E et al. (2010) RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.

Schramek D et al. (2010) Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Hanada R et. al. (2009) Central control of fever and female body temperature by RANKL/RANK.

Guerrini MM et. al. (2008) Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Elahi E et. al. (2007) Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutation.

Jones DH et al. (2006) Regulation of cancer cell migration and bone metastasis by RANKL.

Kapur RP et al. (2004) Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.

Johnson-Pais TL et. al. (2003) Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.

Palenzuela L et. al. (2002) Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene.

Whyte MP et. al. (2002) Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis.

Hocking LJ et al. (2001) Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35.

Marco-Mingot M et al. (2001) Lack of mutations in the RANK gene in Spanish patients with Paget disease of bone.

Sparks AB et al. (2001) Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.

Wuyts W et al. (2001) Evaluation of the role of RANK and OPG genes in Paget's disease of bone.

Good D et al. (2001) Familial Paget's disease of bone: nonlinkage to the PDB1 and PDB2 loci on chromosomes 6p and 18q in a large pedigree.

Hocking L et al. (2000) Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q.

Li J et al. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

Hughes AE et. al. (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Dougall WC et al. (1999) RANK is essential for osteoclast and lymph node development.

Nakagawa N et al. (1998) RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

Nellissery MJ et al. (1998) Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone.

Anderson DM et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Blair HC et. al. (2004) In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.